Yannick Plétan

Yannick Plétan currently works at ULTRace Development Partner, as Chief Executive Officer, Deinove SA, as Independent Director & Chief Medical Officer from 2017, NH TherAguix SAS, as Director from 2019, NFL Biosciences SAS, as Independent Director from 2024, F.
Hoffmann-La Roche Ltd., as Member-Global Medical Affairs, Crossject SA, as Member-Supervisory Board, and Acticor Biotech SAS, as Chief Medical Officer & General Manager.
Dr. Plétan also formerly worked at Ridoret Distribution SARL, as Country Medical Director, Roche SAS, as Country Medical Director, Pfizer SAS (France), as Director, VP, Head-Medical & Scientific Division, Sanofi, as Head-Global Immunology R&D, and Pierre Fabre SA, as Chief Medical Officer.
Dr. Plétan received his doctorate degree from Université de Paris 5 René Descartes and graduate degree from Harvard Business School.